Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
Fusion Acquisition CEO in talks to launch SPAC to list in London, Reuters says » 12:12
06/16/21
06/16
12:12
06/16/21
12:12
FUSE

Fusion Acquisition

$9.94 /

-0.01 (-0.10%)

, JPM

JPMorgan

$154.71 /

-0.52 (-0.33%)

Fusion Acquisition (FUSE)…

Fusion Acquisition (FUSE) CEO John James is in discussions to roll out a new special purpose acquisition company which could list in London in the coming weeks with the goal of becoming the first to take advantage of a new British SPAC regime, Reuters' Pamela Barbaglia and Abhinav Ramnarayan report, citing sources. James, who already oversees two Nasdaq-listed SPACs, is working with JPMorgan (JPM) on a third Fusion blank-check company, the authors say. Reference Link

ShowHide Related Items >><<
JPM JPMorgan
$154.71 /

-0.52 (-0.33%)

FUSE Fusion Acquisition
$9.94 /

-0.01 (-0.10%)

FUSE Fusion Acquisition
$9.94 /

-0.01 (-0.10%)

JPM JPMorgan
$154.71 /

-0.52 (-0.33%)

06/15/21 BMO Capital
JPMorgan price target trimmed to $139 at BMO Capital on reduced NII view
06/14/21 Evercore ISI
Synchrony price target raised to $56 from $49 at Evercore ISI
06/08/21 Wells Fargo
JPMorgan price target raised to $200 from $195 at Wells Fargo
05/06/21 JMP Securities
Walker & Dunlop price target raised to $130 from $70 at JMP Securities
JPM JPMorgan
$154.71 /

-0.52 (-0.33%)

JPM JPMorgan
$154.71 /

-0.52 (-0.33%)

JPM JPMorgan
$154.71 /

-0.52 (-0.33%)

FUSE Fusion Acquisition
$9.94 /

-0.01 (-0.10%)

JPM JPMorgan
$154.71 /

-0.52 (-0.33%)

FUSE Fusion Acquisition
$9.94 /

-0.01 (-0.10%)

Recommendations
Goldman Sachs price target raised to $452 from $351 at JPMorgan » 07:31
06/16/21
06/16
07:31
06/16/21
07:31
GS

Goldman Sachs

$371.23 /

-1.67 (-0.45%)

JPMorgan analyst Kian…

JPMorgan analyst Kian Abouhossein raised the firm's price target on Goldman Sachs to $452 from $351 and keeps an Overweight rating on the shares. The investment banking industry "is in a much better shape today compared to where it has ever been" due to the transformation to a more sustainable, lower capital intensive business, focus on captive sustainable revenue streams and higher barriers of entry, Abouhossein tells investors in a research note. The analyst believes the industry is "well positioned for undiscounted growth." The growth outlook and reduced risk profile, combined with the high barriers of entry in the business, should enable "Tier I" investment banking businesses to command a higher price-to-earnings multiple both absolute and relative compared to retail banking, contends Abouhossein.

ShowHide Related Items >><<
GS Goldman Sachs
$371.23 /

-1.67 (-0.45%)

GS Goldman Sachs
$371.23 /

-1.67 (-0.45%)

06/09/21 Jefferies
Jefferies starts 'too cheap' Goldman Sachs at Buy
06/09/21 Jefferies
Goldman Sachs initiated with a Buy at Jefferies
06/01/21 Piper Sandler
Goldman Sachs price target raised to $420 from $385 at Piper Sandler
05/12/21 Wells Fargo
Summer travel should be catalyst for commercial aero, says Wells Fargo
GS Goldman Sachs
$371.23 /

-1.67 (-0.45%)

GS Goldman Sachs
$371.23 /

-1.67 (-0.45%)

GS Goldman Sachs
$371.23 /

-1.67 (-0.45%)

GS Goldman Sachs
$371.23 /

-1.67 (-0.45%)

Tuesday
Recommendations
JPMorgan price target trimmed to $139 at BMO Capital on reduced NII view » 06:54
06/15/21
06/15
06:54
06/15/21
06:54
JPM

JPMorgan

$157.58 /

-2.71 (-1.69%)

BMO Capital analyst James…

BMO Capital analyst James Fotheringham lowered the firm's price target on JPMorgan to $139 from $140 and keeps a Market Perform rating on the shares. The analyst cites the company's updated guidance yesterday calling for 2021 net interest income of $52.5B vs. $55B prior forecast. Fotheringham adds that JPMorgan's digital investments, earnings diversification, strong balance sheet, and deep bench of management talent should make the stock an "industry winner" for long term investors, but given his two-year-forward valuation-sensitive outlook, he prefers a neutral stance.

ShowHide Related Items >><<
JPM JPMorgan
$157.58 /

-2.71 (-1.69%)

JPM JPMorgan
$157.58 /

-2.71 (-1.69%)

06/14/21 Evercore ISI
Synchrony price target raised to $56 from $49 at Evercore ISI
06/08/21 Wells Fargo
JPMorgan price target raised to $200 from $195 at Wells Fargo
05/06/21 JMP Securities
Walker & Dunlop price target raised to $130 from $70 at JMP Securities
04/30/21 Wells Fargo
JPMorgan price target raised to $195 from $190 at Wells Fargo
JPM JPMorgan
$157.58 /

-2.71 (-1.69%)

JPM JPMorgan
$157.58 /

-2.71 (-1.69%)

JPM JPMorgan
$157.58 /

-2.71 (-1.69%)

JPM JPMorgan
$157.58 /

-2.71 (-1.69%)

Monday
Periodicals
JPMorgan hoarding cash, waiting for interest rate hikes, Reuters reports » 15:10
06/14/21
06/14
15:10
06/14/21
15:10
JPM

JPMorgan

$156.86 /

-3.43 (-2.14%)

JPMorgan CEO Jamie Dimon…

JPMorgan CEO Jamie Dimon said the bank is holding approximately $500B in cash, positioning it to benefit from interest rates hikes, Reuters reports. "We've actually been effectively stockpiling more and more cash, waiting for opportunities to invest at higher rates," Dimon said during a virtual conference held by Morgan Stanley. "So our balance sheet is positioned to benefit from rising rates." Reference Link

ShowHide Related Items >><<
JPM JPMorgan
$156.86 /

-3.43 (-2.14%)

JPM JPMorgan
$156.86 /

-3.43 (-2.14%)

06/14/21 Evercore ISI
Synchrony price target raised to $56 from $49 at Evercore ISI
06/08/21 Wells Fargo
JPMorgan price target raised to $200 from $195 at Wells Fargo
05/06/21 JMP Securities
Walker & Dunlop price target raised to $130 from $70 at JMP Securities
04/30/21 Wells Fargo
JPMorgan price target raised to $195 from $190 at Wells Fargo
JPM JPMorgan
$156.86 /

-3.43 (-2.14%)

JPM JPMorgan
$156.86 /

-3.43 (-2.14%)

JPM JPMorgan
$156.86 /

-3.43 (-2.14%)

JPM JPMorgan
$156.86 /

-3.43 (-2.14%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:02
06/14/21
06/14
12:02
06/14/21
12:02
NVAX

Novavax

$203.46 /

-6.14 (-2.93%)

, MRNA

Moderna

$205.25 /

-13.55 (-6.19%)

, RIDE

Lordstown Motors

$9.39 /

-2.01 (-17.63%)

, TSLA

Tesla

$616.70 /

+6.78 (+1.11%)

, WPG

Washington Prime

$3.71 /

-1.135 (-23.45%)

, CMG

Chipotle

$1,393.00 /

+25.71 (+1.88%)

, OTLY

Oatly Group

$27.64 /

-1.07 (-3.73%)

, CRSP

Crispr Therapeutics

$128.47 /

+1.39 (+1.09%)

, CLB

Core Laboratories

$47.61 /

-0.1 (-0.21%)

, AVB

AvalonBay

$212.92 /

-1.57 (-0.73%)

, VIVHY

Vivendi

$35.07 /

-0.13 (-0.37%)

, NGAC

NextGen Acquisition Corp.

$10.01 /

+0.01 (+0.10%)

, GSK

GlaxoSmithKline

$40.32 /

+0.17 (+0.42%)

, GS

Goldman Sachs

$373.62 /

-4.4 (-1.16%)

, RDS.A

Royal Dutch Shell

$41.47 /

+1.055 (+2.61%)

, RDS.B

Royal Dutch Shell

$39.26 /

+1.015 (+2.65%)

, RAPT

Rapt Therapeutics

$38.82 /

+20.225 (+108.77%)

, ITOS

iTeos Therapeutics

$27.55 /

+7.55 (+37.75%)

, BTX

Brooklyn ImmunoTherapeutics

$15.49 /

+1.04 (+7.20%)

, ENDP

Endo

$5.79 /

-0.46 (-7.36%)

, FBIO

Fortress Biotech

$3.94 /

-0.55 (-12.25%)

, BITCOIN

Bitcoin

/

+

, BTC

Bitcoin

/

+

, $BTC

Bitcoin

/

+

, MPAA

Motorcar Parts

$24.61 /

+1.37 (+5.90%)

, KLR

Kaleyra

$11.80 /

-0.6 (-4.84%)

, CANO

Cano Health

$15.02 /

+0.295 (+2.00%)

, CODA

Coda Octopus Group

$9.73 /

+0.58 (+6.34%)

, DUK

Duke Energy

$101.94 /

+0.01 (+0.01%)

1. STOCK NEWS: …

ShowHide Related Items >><<
WPG Washington Prime
$3.71 /

-1.135 (-23.45%)

VIVHY Vivendi
$35.07 /

-0.13 (-0.37%)

TSLA Tesla
$616.70 /

+6.78 (+1.11%)

RIDE Lordstown Motors
$9.39 /

-2.01 (-17.63%)

RDS.B Royal Dutch Shell
$39.26 /

+1.015 (+2.65%)

RDS.A Royal Dutch Shell
$41.47 /

+1.055 (+2.61%)

RAPT Rapt Therapeutics
$38.82 /

+20.225 (+108.77%)

NVAX Novavax
$203.46 /

-6.14 (-2.93%)

NGAC NextGen Acquisition Corp.
$10.01 /

+0.01 (+0.10%)

MRNA Moderna
$205.25 /

-13.55 (-6.19%)

MPAA Motorcar Parts
$24.61 /

+1.37 (+5.90%)

KLR Kaleyra
$11.80 /

-0.6 (-4.84%)

ITOS iTeos Therapeutics
$27.55 /

+7.55 (+37.75%)

GSK GlaxoSmithKline
$40.32 /

+0.17 (+0.42%)

GS Goldman Sachs
$373.62 /

-4.4 (-1.16%)

FBIO Fortress Biotech
$3.94 /

-0.55 (-12.25%)

ENDP Endo
$5.79 /

-0.46 (-7.36%)

DUK Duke Energy
$101.94 /

+0.01 (+0.01%)

CRSP Crispr Therapeutics
$128.47 /

+1.39 (+1.09%)

CMG Chipotle
$1,393.00 /

+25.71 (+1.88%)

CLB Core Laboratories
$47.61 /

-0.1 (-0.21%)

CANO Cano Health
$15.02 /

+0.295 (+2.00%)

BTX Brooklyn ImmunoTherapeutics
$15.49 /

+1.04 (+7.20%)

BTC Bitcoin
/

+

BITCOIN Bitcoin
/

+

AVB AvalonBay
$212.92 /

-1.57 (-0.73%)

NVAX Novavax
$203.46 /

-6.14 (-2.93%)

06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
05/12/21
Fly Intel: Top five analyst downgrades
05/12/21 B. Riley
Novavax price target lowered to $286 from $365 at B. Riley
05/12/21 Cantor Fitzgerald
Novavax price target lowered to $217 from $338 at Cantor Fitzgerald
MRNA Moderna
$205.25 /

-13.55 (-6.19%)

06/10/21 Piper Sandler
Moderna should be vaccinating teens this summer, says Piper Sandler
06/07/21 Piper Sandler
Moderna price target raised to $246 from $231 at Piper Sandler
05/21/21 Piper Sandler
Piper says overseas approvals providing 'second leg of growth' for Moderna
05/07/21 Barclays
Moderna price target raised to $194 from $178 at Barclays
RIDE Lordstown Motors
$9.39 /

-2.01 (-17.63%)

06/14/21 R.F. Lafferty
R.F. Lafferty downgrades Lordstown to Sell with $3 target on uncertainty
06/14/21 R.F. Lafferty
Lordstown Motors downgraded to Sell from Hold at R.F. Lafferty
06/10/21 Morgan Stanley
Morgan Stanley removes Lordstown rating, says market may be underestimating risk
06/08/21 RBC Capital
Lordstown Motors initiated with an Underperform at RBC Capital
TSLA Tesla
$616.70 /

+6.78 (+1.11%)

06/14/21 Canaccord
Tesla price target lowered to $812 from $974 at Canaccord
06/11/21 Credit Suisse
Tesla's Model S Plaid reinforces brand DNA, says Credit Suisse
06/11/21 Goldman Sachs
Goldman says Tesla's Model S Plaid helps illustrate technology leadership
06/08/21 GLJ Research
Tesla's China orders down 69% in Q2 versus Q1, says GLJ Research
WPG Washington Prime
$3.71 /

-1.135 (-23.45%)

04/06/21 Truist
Washington Prime upgraded to Hold from Sell at Truist
04/05/21 Truist
Washington Prime upgraded to Hold from Sell at Truist
02/16/21 Truist
Washington Prime coupon non-payment part of negotiating process, says Truist
02/01/21 Truist
Macerich Q4 results 'weak,' but not much worse than expected, says Truist
CMG Chipotle
$1,393.00 /

+25.71 (+1.88%)

06/14/21
Fly Intel: Top five analyst upgrades
06/14/21 Wells Fargo
Chipotle price target lowered to $1,720 from $1,818 at Wells Fargo
06/14/21 Raymond James
Raymond James upgrades Chipotle to Strong Buy on menu price hikes
06/14/21 Raymond James
Chipotle upgraded to Strong Buy from Outperform at Raymond James
OTLY Oatly Group
$27.64 /

-1.07 (-3.73%)

06/14/21
Fly Intel: Top five analyst initiations
06/14/21 Jefferies
Oatly Group initiated with a Buy at Jefferies
06/14/21 JPMorgan
Oatly Group initiated with a Neutral at JPMorgan
06/14/21 Truist
Oatly Group initiated with a Buy at Truist
CRSP Crispr Therapeutics
$128.47 /

+1.39 (+1.09%)

06/14/21 Citi
Crispr Therapeutics upgraded to Neutral from Sell at Citi
06/11/21 Roth Capital
Crispr Therapeutics reported 'robust' sickle cell data, says Roth Capital
05/13/21 Evercore ISI
Crispr Therapeutics upgraded to Outperform from In Line at Evercore ISI
CLB Core Laboratories
$47.61 /

-0.1 (-0.21%)

06/14/21
Fly Intel: Top five analyst downgrades
06/14/21 Citi
Core Laboratories downgraded to Sell from Neutral at Citi
04/23/21 Citi
Core Laboratories price target lowered to $30 from $36 at Citi
01/11/21 Wolfe Research
Core Laboratories upgraded to Peer Perform from Underperform at Wolfe Research
AVB AvalonBay
$212.92 /

-1.57 (-0.73%)

06/14/21 Evercore ISI
AvalonBay downgraded to In Line from Outperform at Evercore ISI
06/11/21 Morgan Stanley
AvalonBay price target raised to $218 from $210 at Morgan Stanley
06/04/21 Truist
AvalonBay downgraded to Hold from Buy at Truist on premium valuation
VIVHY Vivendi
$35.07 /

-0.13 (-0.37%)

06/01/21
Fly Intel: Top five analyst downgrades
06/01/21 Bernstein
Vivendi downgraded to Market Perform from Outperform at Bernstein
05/14/21 Credit Suisse
Vivendi price target lowered to EUR 32.20 from EUR 32.40 at Credit Suisse
04/23/21 Barclays
Vivendi price target raised to EUR 32 from EUR 31 at Barclays
NGAC NextGen Acquisition Corp.
$10.01 /

+0.01 (+0.10%)

06/11/21 Benchmark
NextGen Acquisition Corp. initiated with a Buy at Benchmark
GSK GlaxoSmithKline
$40.32 /

+0.17 (+0.42%)

06/14/21 Piper Sandler
iTeos deal 'addresses a number of needs all at once, says Piper Sandler
06/11/21 Deutsche Bank
GlaxoSmithKline price target raised to 1,300 GBp at Deutsche Bank
05/27/21 Piper Sandler
Xencorc royalty revenue streams growing, says Piper Sandler
05/11/21 UBS
GlaxoSmithKline price target raised to 1,370 GBp from 1,360 GBp at UBS
GS Goldman Sachs
$373.62 /

-4.4 (-1.16%)

06/09/21 Jefferies
Jefferies starts 'too cheap' Goldman Sachs at Buy
06/09/21 Jefferies
Goldman Sachs initiated with a Buy at Jefferies
06/01/21 Piper Sandler
Goldman Sachs price target raised to $420 from $385 at Piper Sandler
05/12/21 Wells Fargo
Summer travel should be catalyst for commercial aero, says Wells Fargo
RDS.A Royal Dutch Shell
$41.47 /

+1.055 (+2.61%)

06/08/21 DZ Bank
Royal Dutch Shell downgraded to Hold from Buy at DZ Bank
05/17/21 Mizuho
Royal Dutch Shell price target raised to $61 from $56 at Mizuho
04/30/21 Credit Suisse
Royal Dutch Shell price target raised to 1,860 GBp at Credit Suisse
04/20/21 Deutsche Bank
Royal Dutch Shell initiated with a Buy at Deutsche Bank
RDS.B Royal Dutch Shell
$39.26 /

+1.015 (+2.65%)

04/08/21 Barclays
Royal Dutch Shell price target raised to 1,700 GBp from 1,500 GBp at Barclays
03/12/21 Societe Generale
Royal Dutch Shell upgraded to Buy from Hold at Societe Generale
03/03/21 JPMorgan
Royal Dutch Shell price target raised to 2,000 GBp from 1,700 GBp at JPMorgan
02/12/21 Scotiabank
Royal Dutch Shell upgraded to Sector Perform from Underperform at Scotiabank
RAPT Rapt Therapeutics
$38.82 /

+20.225 (+108.77%)

06/14/21 Cantor Fitzgerald
Cantor ups Rapt target to $71 after 'robust' atopic dermatitis data
06/14/21 Cantor Fitzgerald
Rapt Therapeutics price target raised to $71 from $51 at Cantor Fitzgerald
05/17/21 H.C. Wainwright
Rapt Therapeutics price target lowered to $29 from $32 at H.C. Wainwright
04/12/21 Roth Capital
Roth says Rapt Therapeutics' AACR presentations highlight broad potential
ITOS iTeos Therapeutics
$27.55 /

+7.55 (+37.75%)

05/19/21 SVB Leerink
iTeos Therapeutics price target lowered to $45 from $60 at SVB Leerink
05/14/21 Piper Sandler
iTeos Therapeutics recent pullback unwarranted, says Piper Sandler
05/05/21 H.C. Wainwright
iTeos Therapeutics initiated with a Buy at H.C. Wainwright
BTX Brooklyn ImmunoTherapeutics
$15.49 /

+1.04 (+7.20%)

ENDP Endo
$5.79 /

-0.46 (-7.36%)

05/17/21 Citi
Endo price target raised to $11 from $10 at Citi
04/06/21 RBC Capital
Endo transferred with a Sector Perform at RBC Capital
03/08/21 Barclays
Endo price target raised to $7 from $6 at Barclays
03/04/21 Citi
Endo price target lowered to $10 from $11 at Citi
FBIO Fortress Biotech
$3.94 /

-0.55 (-12.25%)

04/14/21 B. Riley
Fortress Biotech weakness yesterday a buying opportunity, says B. Riley
04/05/21 B. Riley
Fortress Biotech price target raised to $9 from $8 at B. Riley
02/17/21 Dawson James
Fortress Biotech price target raised to $21 from $16 at Dawson James
12/14/20 Benchmark
Decision looms on Fortress' Caelum after partner Alexion bought, says Benchmark
BITCOIN Bitcoin
/

+

05/13/21 BTIG
BTIG sees Binance news as 'net positive' for Coinbase
04/27/21 Roth Capital
Regulatory credits, bitcoin fuel Tesla Q1 headline beat, says Roth Capital
04/15/21 Morgan Stanley
WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley
BTC Bitcoin
/

+

01/13/21 Standpoint Research
Bitcoin could hit $112,000 this year, says Standpoint Research
$BTC Bitcoin
/

+

MPAA Motorcar Parts
$24.61 /

+1.37 (+5.90%)

02/04/21 B. Riley
Motorcar Parts price target raised to $28 from $25 at B. Riley Securities
08/11/20 Craig-Hallum
Motorcar Parts downgraded to Hold from Buy at Craig-Hallum
07/01/20 B. Riley
Motorcar Parts transferred with Buy rating at B. Riley FBR
06/19/20 Roth Capital
Motorcar Parts assumed with a Buy at Roth Capital
KLR Kaleyra
$11.80 /

-0.6 (-4.84%)

06/11/21 Northland
Kaleyra price target raised to $29 from $23 at Northland
03/19/21 Northland
Kaleyra on track for 21% growth in Q1, says Northland
02/22/21 Maxim
Kaleyra price target raised to $42 from $30 at Maxim
02/17/21 Craig-Hallum
Kaleyra price target raised to $25 from $20 at Craig-Hallum
CANO Cano Health
$15.02 /

+0.295 (+2.00%)

11/19/20 Compass Point
Compass Point upgrades PennantPark to Buy after Cano Health 'game changer'
CODA Coda Octopus Group
$9.73 /

+0.58 (+6.34%)

DUK Duke Energy
$101.94 /

+0.01 (+0.01%)

05/18/21 Morgan Stanley
Morgan Stanley sees 'low probability' Duke Energy and Elliott reach agreement
05/12/21 Mizuho
Duke Energy price target raised to $105 from $96 at Mizuho
04/14/21 Credit Suisse
Duke Energy price target raised to $104 from $96 at Credit Suisse
04/14/21 Wells Fargo
Duke Energy price target raised to $104 from $97 at Wells Fargo
WPG Washington Prime
$3.71 /

-1.135 (-23.45%)

TSLA Tesla
$616.70 /

+6.78 (+1.11%)

RIDE Lordstown Motors
$9.39 /

-2.01 (-17.63%)

RDS.A Royal Dutch Shell
$41.47 /

+1.055 (+2.61%)

RAPT Rapt Therapeutics
$38.82 /

+20.225 (+108.77%)

NVAX Novavax
$203.46 /

-6.14 (-2.93%)

MRNA Moderna
$205.25 /

-13.55 (-6.19%)

MPAA Motorcar Parts
$24.61 /

+1.37 (+5.90%)

KLR Kaleyra
$11.80 /

-0.6 (-4.84%)

ITOS iTeos Therapeutics
$27.55 /

+7.55 (+37.75%)

GSK GlaxoSmithKline
$40.32 /

+0.17 (+0.42%)

GS Goldman Sachs
$373.62 /

-4.4 (-1.16%)

FBIO Fortress Biotech
$3.94 /

-0.55 (-12.25%)

ENDP Endo
$5.79 /

-0.46 (-7.36%)

DUK Duke Energy
$101.94 /

+0.01 (+0.01%)

CRSP Crispr Therapeutics
$128.47 /

+1.39 (+1.09%)

CODA Coda Octopus Group
$9.73 /

+0.58 (+6.34%)

CMG Chipotle
$1,393.00 /

+25.71 (+1.88%)

CLB Core Laboratories
$47.61 /

-0.1 (-0.21%)

CANO Cano Health
$15.02 /

+0.295 (+2.00%)

BITCOIN Bitcoin
/

+

AVB AvalonBay
$212.92 /

-1.57 (-0.73%)

  • 20
    May
  • 24
    Jul
  • 01
    Jul
  • 25
    Jun
WPG Washington Prime
$3.71 /

-1.135 (-23.45%)

VIVHY Vivendi
$35.07 /

-0.13 (-0.37%)

TSLA Tesla
$616.70 /

+6.78 (+1.11%)

RIDE Lordstown Motors
$9.39 /

-2.01 (-17.63%)

RDS.B Royal Dutch Shell
$39.26 /

+1.015 (+2.65%)

RDS.A Royal Dutch Shell
$41.47 /

+1.055 (+2.61%)

OTLY Oatly Group
$27.64 /

-1.07 (-3.73%)

NVAX Novavax
$203.46 /

-6.14 (-2.93%)

NGAC NextGen Acquisition Corp.
$10.01 /

+0.01 (+0.10%)

MRNA Moderna
$205.25 /

-13.55 (-6.19%)

GSK GlaxoSmithKline
$40.32 /

+0.17 (+0.42%)

GS Goldman Sachs
$373.62 /

-4.4 (-1.16%)

ENDP Endo
$5.79 /

-0.46 (-7.36%)

DUK Duke Energy
$101.94 /

+0.01 (+0.01%)

CMG Chipotle
$1,393.00 /

+25.71 (+1.88%)

BITCOIN Bitcoin
/

+

VIVHY Vivendi
$35.07 /

-0.13 (-0.37%)

TSLA Tesla
$616.70 /

+6.78 (+1.11%)

RIDE Lordstown Motors
$9.39 /

-2.01 (-17.63%)

RDS.B Royal Dutch Shell
$39.26 /

+1.015 (+2.65%)

RDS.A Royal Dutch Shell
$41.47 /

+1.055 (+2.61%)

OTLY Oatly Group
$27.64 /

-1.07 (-3.73%)

NVAX Novavax
$203.46 /

-6.14 (-2.93%)

NGAC NextGen Acquisition Corp.
$10.01 /

+0.01 (+0.10%)

MRNA Moderna
$205.25 /

-13.55 (-6.19%)

KLR Kaleyra
$11.80 /

-0.6 (-4.84%)

GSK GlaxoSmithKline
$40.32 /

+0.17 (+0.42%)

GS Goldman Sachs
$373.62 /

-4.4 (-1.16%)

FBIO Fortress Biotech
$3.94 /

-0.55 (-12.25%)

ENDP Endo
$5.79 /

-0.46 (-7.36%)

DUK Duke Energy
$101.94 /

+0.01 (+0.01%)

CRSP Crispr Therapeutics
$128.47 /

+1.39 (+1.09%)

CMG Chipotle
$1,393.00 /

+25.71 (+1.88%)

CLB Core Laboratories
$47.61 /

-0.1 (-0.21%)

BTX Brooklyn ImmunoTherapeutics
$15.49 /

+1.04 (+7.20%)

BITCOIN Bitcoin
/

+

WPG Washington Prime
$3.71 /

-1.135 (-23.45%)

TSLA Tesla
$616.70 /

+6.78 (+1.11%)

RIDE Lordstown Motors
$9.39 /

-2.01 (-17.63%)

OTLY Oatly Group
$27.64 /

-1.07 (-3.73%)

NVAX Novavax
$203.46 /

-6.14 (-2.93%)

NGAC NextGen Acquisition Corp.
$10.01 /

+0.01 (+0.10%)

MRNA Moderna
$205.25 /

-13.55 (-6.19%)

KLR Kaleyra
$11.80 /

-0.6 (-4.84%)

GSK GlaxoSmithKline
$40.32 /

+0.17 (+0.42%)

GS Goldman Sachs
$373.62 /

-4.4 (-1.16%)

FBIO Fortress Biotech
$3.94 /

-0.55 (-12.25%)

ENDP Endo
$5.79 /

-0.46 (-7.36%)

CRSP Crispr Therapeutics
$128.47 /

+1.39 (+1.09%)

CMG Chipotle
$1,393.00 /

+25.71 (+1.88%)

CANO Cano Health
$15.02 /

+0.295 (+2.00%)

BTX Brooklyn ImmunoTherapeutics
$15.49 /

+1.04 (+7.20%)

Periodicals
Goldman Sachs in talks to move some employees to Florida, BI reports » 11:28
06/14/21
06/14
11:28
06/14/21
11:28
GS

Goldman Sachs

$374.18 /

-3.84 (-1.02%)

Goldman Sachs is in talks…

Goldman Sachs is in talks to move more than 100 salespeople and traders to West Palm Beach from Manhattan, Business Insider's Dakin Campbell reports. Reference Link

ShowHide Related Items >><<
GS Goldman Sachs
$374.18 /

-3.84 (-1.02%)

GS Goldman Sachs
$374.18 /

-3.84 (-1.02%)

06/09/21 Jefferies
Jefferies starts 'too cheap' Goldman Sachs at Buy
06/09/21 Jefferies
Goldman Sachs initiated with a Buy at Jefferies
06/01/21 Piper Sandler
Goldman Sachs price target raised to $420 from $385 at Piper Sandler
05/12/21 Wells Fargo
Summer travel should be catalyst for commercial aero, says Wells Fargo
GS Goldman Sachs
$374.18 /

-3.84 (-1.02%)

GS Goldman Sachs
$374.18 /

-3.84 (-1.02%)

GS Goldman Sachs
$374.18 /

-3.84 (-1.02%)

GS Goldman Sachs
$374.18 /

-3.84 (-1.02%)

Hot Stocks
JPMorgan prepared for higher rates, more inflation, CEO says  11:09
06/14/21
06/14
11:09
06/14/21
11:09
JPM

JPMorgan

$159.61 /

-0.68 (-0.42%)

 
ShowHide Related Items >><<
JPM JPMorgan
$159.61 /

-0.68 (-0.42%)

JPM JPMorgan
$159.61 /

-0.68 (-0.42%)

06/14/21 Evercore ISI
Synchrony price target raised to $56 from $49 at Evercore ISI
06/08/21 Wells Fargo
JPMorgan price target raised to $200 from $195 at Wells Fargo
05/06/21 JMP Securities
Walker & Dunlop price target raised to $130 from $70 at JMP Securities
04/30/21 Wells Fargo
JPMorgan price target raised to $195 from $190 at Wells Fargo
JPM JPMorgan
$159.61 /

-0.68 (-0.42%)

JPM JPMorgan
$159.61 /

-0.68 (-0.42%)

JPM JPMorgan
$159.61 /

-0.68 (-0.42%)

JPM JPMorgan
$159.61 /

-0.68 (-0.42%)

Hot Stocks
JPMorgan sees FY NII $52.5B, CEO Dimon says  11:09
06/14/21
06/14
11:09
06/14/21
11:09
JPM

JPMorgan

$159.58 /

-0.71 (-0.44%)

 
ShowHide Related Items >><<
JPM JPMorgan
$159.58 /

-0.71 (-0.44%)

JPM JPMorgan
$159.58 /

-0.71 (-0.44%)

06/14/21 Evercore ISI
Synchrony price target raised to $56 from $49 at Evercore ISI
06/08/21 Wells Fargo
JPMorgan price target raised to $200 from $195 at Wells Fargo
05/06/21 JMP Securities
Walker & Dunlop price target raised to $130 from $70 at JMP Securities
04/30/21 Wells Fargo
JPMorgan price target raised to $195 from $190 at Wells Fargo
JPM JPMorgan
$159.58 /

-0.71 (-0.44%)

JPM JPMorgan
$159.58 /

-0.71 (-0.44%)

JPM JPMorgan
$159.58 /

-0.71 (-0.44%)

JPM JPMorgan
$159.58 /

-0.71 (-0.44%)

Hot Stocks
JPMorgan sees Q2 trading revenue north of $6B » 11:09
06/14/21
06/14
11:09
06/14/21
11:09
JPM

JPMorgan

$159.58 /

-0.71 (-0.44%)

Comments made by CEO…

Comments made by CEO Jamie Dimon at the Morgan Stanley US Financials Conference.

ShowHide Related Items >><<
JPM JPMorgan
$159.58 /

-0.71 (-0.44%)

JPM JPMorgan
$159.58 /

-0.71 (-0.44%)

06/14/21 Evercore ISI
Synchrony price target raised to $56 from $49 at Evercore ISI
06/08/21 Wells Fargo
JPMorgan price target raised to $200 from $195 at Wells Fargo
05/06/21 JMP Securities
Walker & Dunlop price target raised to $130 from $70 at JMP Securities
04/30/21 Wells Fargo
JPMorgan price target raised to $195 from $190 at Wells Fargo
JPM JPMorgan
$159.58 /

-0.71 (-0.44%)

JPM JPMorgan
$159.58 /

-0.71 (-0.44%)

JPM JPMorgan
$159.58 /

-0.71 (-0.44%)

JPM JPMorgan
$159.58 /

-0.71 (-0.44%)

Recommendations
Synchrony price target raised to $56 from $49 at Evercore ISI » 08:27
06/14/21
06/14
08:27
06/14/21
08:27
SYF

Synchrony

$49.36 /

+0.37 (+0.76%)

, JPM

JPMorgan

$160.29 /

-0.11 (-0.07%)

, AMZN

Amazon.com

$3,346.75 /

-3.33 (-0.10%)

Evercore ISI analyst John…

Evercore ISI analyst John Pancari raised the firm's price target on Synchrony Financial (SYF) to $56 from $49 and keeps an Outperform rating on the shares. Bloomberg reported that Synchrony is potentially in the running to win Amazon's (AMZN) co-branded card business, which is expected to shift from JPMorgan (JPM) to a new provider, Evercore ISI analyst John Pancari tells investors in a research note. The analyst estimates a potential transaction could add as much as 10% to Synchrony's annual pre-tax income, assuming the sizable $15B back book is also acquired. Despite the scale of the business, the financial contribution of the Amazon deal is likely to be limited by "particularly thin pricing," adds Pancari. He believes the underlying profitability of the Amazon relationship to Synchrony will be heavily predicated on sheer transaction volume and increased the price target to reflect higher sector multiples and a constructive outlook on the shares.

ShowHide Related Items >><<
SYF Synchrony
$49.36 /

+0.37 (+0.76%)

JPM JPMorgan
$160.29 /

-0.11 (-0.07%)

AMZN Amazon.com
$3,346.75 /

-3.33 (-0.10%)

SYF Synchrony
$49.36 /

+0.37 (+0.76%)

04/28/21 Deutsche Bank
Synchrony price target raised to $58 from $54 at Deutsche Bank
04/15/21 JPMorgan
Synchrony price target lowered to $48 from $49 at JPMorgan
04/14/21
Fly Intel: Top five analyst downgrades
04/14/21 Oppenheimer
Synchrony downgraded to Perform at Oppenheimer
JPM JPMorgan
$160.29 /

-0.11 (-0.07%)

06/08/21 Wells Fargo
JPMorgan price target raised to $200 from $195 at Wells Fargo
05/06/21 JMP Securities
Walker & Dunlop price target raised to $130 from $70 at JMP Securities
04/30/21 Wells Fargo
JPMorgan price target raised to $195 from $190 at Wells Fargo
04/27/21 Atlantic Equities
JPMorgan downgraded to Neutral from Overweight at Atlantic Equities
AMZN Amazon.com
$3,346.75 /

-3.33 (-0.10%)

06/08/21 Piper Sandler
New Amazon offering targets Hims & Hers and others, says Piper Sandler
06/08/21 UBS
Snowflake price target raised to $300 from $275 at UBS
06/07/21 Loop Capital
Best Buy prices remain 'very competitive' to Amazon's, says Loop Capital
06/07/21 Roth Capital
iPower initiated with a Buy at Roth Capital
SYF Synchrony
$49.36 /

+0.37 (+0.76%)

JPM JPMorgan
$160.29 /

-0.11 (-0.07%)

AMZN Amazon.com
$3,346.75 /

-3.33 (-0.10%)

SYF Synchrony
$49.36 /

+0.37 (+0.76%)

JPM JPMorgan
$160.29 /

-0.11 (-0.07%)

AMZN Amazon.com
$3,346.75 /

-3.33 (-0.10%)

SYF Synchrony
$49.36 /

+0.37 (+0.76%)

JPM JPMorgan
$160.29 /

-0.11 (-0.07%)

AMZN Amazon.com
$3,346.75 /

-3.33 (-0.10%)

JPM JPMorgan
$160.29 /

-0.11 (-0.07%)

AMZN Amazon.com
$3,346.75 /

-3.33 (-0.10%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.